Immunotherapy in Malaysia

Avg. Cost: RM 1,000

Overview

Targeted therapy and immunotherapy represent the most significant advances in cancer treatment in recent decades. Targeted agents (TKIs, monoclonal antibodies) block specific proteins or pathways that drive cancer growth — examples include EGFR inhibitors for lung cancer, HER2 inhibitors for breast cancer, and BCR-ABL inhibitors for leukaemia. Immunotherapy agents (checkpoint inhibitors: PD-1, PD-L1, CTLA-4 inhibitors) release the immune system's brakes, allowing T cells to recognise and attack cancer. These treatments are administered as IV infusions or oral tablets and have transformed outcomes in many cancer types.

Top 20 doctors for Immunotherapy in Malaysia

Available Hospitals

Cancer Immunotherapy by city